Nektar Therapeutics
NKTR
$56.90
-$2.02-3.43%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 175.90M | 218.63M | 255.23M | 244.50M | 271.24M |
Total Receivables | 1.35M | 1.71M | 1.61M | 2.12M | 2.90M |
Inventory | -- | -- | -- | -- | 14.47M |
Prepaid Expenses | 1.73M | 2.21M | 2.51M | 2.85M | 2.38M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 7.58M | 7.36M | 1.95M | 37.01M | 4.21M |
Total Current Assets | 186.57M | 229.91M | 261.29M | 286.48M | 295.19M |
|
|||||
Total Current Assets | 186.57M | 229.91M | 261.29M | 286.48M | 295.19M |
Net Property, Plant & Equipment | 10.57M | 11.16M | 11.82M | 12.43M | 24.43M |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 5.02M | 5.39M | 4.65M | 4.52M | 4.31M |
Total Assets | 207.53M | 256.24M | 303.85M | 307.97M | 343.33M |
|
|||||
Total Accounts Payable | 14.28M | 17.83M | 11.56M | 8.58M | 6.48M |
Total Accrued Expenses | 31.82M | 28.43M | 27.21M | 29.23M | 26.16M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 22.01M | 21.84M | 19.87M | 21.50M | 21.34M |
Total Finance Division Other Current Liabilities | 3.28M | 2.83M | 2.77M | 8.28M | 3.36M |
Total Other Current Liabilities | 3.28M | 2.83M | 2.77M | 8.28M | 3.36M |
Total Current Liabilities | 71.39M | 70.93M | 61.40M | 67.58M | 57.33M |
|
|||||
Total Current Liabilities | 71.39M | 70.93M | 61.40M | 67.58M | 57.33M |
Long-Term Debt | 80.57M | 86.32M | 91.78M | 97.83M | 107.51M |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 74.15M | 78.50M | 82.70M | 86.76M | 90.76M |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 5.64M | 6.76M | 7.24M | 6.91M | 8.05M |
Total Liabilities | 231.75M | 242.50M | 243.11M | 259.08M | 263.65M |
|
|||||
Common Stock & APIC | 3.67B | 3.66B | 3.66B | 3.66B | 3.65B |
Retained Earnings | -3.69B | -3.65B | -3.60B | -3.60B | -3.57B |
Treasury Stock & Other | -3.01M | -2.96M | -2.94M | -2.65M | -3.49M |
Total Common Equity | -24.21M | 13.74M | 60.74M | 48.88M | 79.69M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -24.21M | 13.74M | 60.74M | 48.88M | 79.69M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -24.21M | 13.74M | 60.74M | 48.88M | 79.69M |
|